America's Car Mart (CRMT) Says Company-Specific Issues and Increased Competition Impacted 2Q Results; Jefferies Cuts Price Target to $29

Go back to America's Car Mart (CRMT) Says Company-Specific Issues and Increased Competition Impacted 2Q Results; Jefferies Cuts Price Target to $29

Unusual 11 Mid-Day Movers 11/20: (KBIO) (MCUR) (SRPT) Higher; (NMBL) (APTO) (MENT) Lower

November 20, 2015 12:46 PM EST

KaloBios Pharma (Nasdaq: KBIO) 81.3% HIGHER; announced that an investor group led by Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares. KaloBios also announced the appointment of Martin Shkreli to the position of Chief Executive Officer and his election as Chairman of the Board. In his new role, Mr. Shkreli will work with the company's senior management team to ensure the Company's continued operations. KaloBios further announced that David Moradi, Tony Chase and Marek Biestek have been elected to the... More

America's Car Mart (CRMT) Misses Q2 EPS. Revenue Expectations

November 19, 2015 8:25 PM EST

America's Car Mart (NASDAQ: CRMT) reported Q2 EPS of $0.29, $0.41 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $133 million versus the consensus estimate of $151.77 million.

Retail unit sales decrease of 10% to 10,881 from 12,084 for the prior year quarter with... More

America's Car Mart (CRMT) Halted, News Pending

November 19, 2015 4:55 PM EST

America's Car Mart (NASDAQ: CRMT) Halted, News Pending

... More